T Halmos

Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population

Björn Fagerberg, S. Edwards, T Halmos et al. · Diabetologia · 2005 · 114 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Plasma lipoprotein(a) concentration and phenotypes in diabetes mellitus

A. Cs�sz�r, Hans Dieplinger, C. Sandholzer et al. · Diabetologia · 1993 · 71 citations · Full text

Medicine, Endocrinology, Internal Medicine +11

Tesaglitazar, a dual peroxisome proliferator-activated receptor α/γ agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance

Herbert Schuster, Björn Fagerberg, S. Edwards et al. · Atherosclerosis · 2007 · 31 citations

Medicine, Endocrinology, Pharmacology +16

Electron microscopic study of liver fibrosis associated with diabetes mellitus

M Balázs, T Halmos · Experimental Pathology · 1985 · 16 citations

Medicine, Pathobiology, Pathology +16

Bone changes in diabetes mellitus.

S Forgács, T Halmos, Ferenc Salamon · PubMed · 1972 · 15 citations

Medicine, Endocrinology, Orthopedic Surgery +13